These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 33131981)

  • 21. Cross-presentation of HCMV chimeric protein enables generation and measurement of polyclonal T cells.
    Nguyen TH; Sullivan LC; Kotsimbos TC; Schwarer AP; Mifsud NA
    Immunol Cell Biol; 2010 Aug; 88(6):676-84. PubMed ID: 20195281
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development of a novel in silico docking simulation model for the fine HIV-1 cytotoxic T lymphocyte epitope mapping.
    Mori M; Matsuki K; Maekawa T; Tanaka M; Sriwanthana B; Yokoyama M; Ariyoshi K
    PLoS One; 2012; 7(7):e41703. PubMed ID: 22848572
    [TBL] [Abstract][Full Text] [Related]  

  • 23. TepiTool: A Pipeline for Computational Prediction of T Cell Epitope Candidates.
    Paul S; Sidney J; Sette A; Peters B
    Curr Protoc Immunol; 2016 Aug; 114():18.19.1-18.19.24. PubMed ID: 27479659
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunoinformatics and Epitope Prediction.
    Ramana J; Mehla K
    Methods Mol Biol; 2020; 2131():155-171. PubMed ID: 32162252
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inefficient cross-presentation limits the CD8+ T cell response to a subdominant tumor antigen epitope.
    Otahal P; Hutchinson SC; Mylin LM; Tevethia MJ; Tevethia SS; Schell TD
    J Immunol; 2005 Jul; 175(2):700-12. PubMed ID: 16002665
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Length Distribution and Multiple Specificity of Naturally Presented HLA-I Ligands.
    Gfeller D; Guillaume P; Michaux J; Pak HS; Daniel RT; Racle J; Coukos G; Bassani-Sternberg M
    J Immunol; 2018 Dec; 201(12):3705-3716. PubMed ID: 30429286
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Advances in the study of HLA-restricted epitope vaccines.
    Zhao L; Zhang M; Cong H
    Hum Vaccin Immunother; 2013 Dec; 9(12):2566-77. PubMed ID: 23955319
    [TBL] [Abstract][Full Text] [Related]  

  • 28. B and T Cell Epitope-Based Peptides Predicted from Evolutionarily Conserved and Whole Protein Sequences of Ebola Virus as Vaccine Targets.
    Yasmin T; Nabi AH
    Scand J Immunol; 2016 May; 83(5):321-37. PubMed ID: 26939891
    [TBL] [Abstract][Full Text] [Related]  

  • 29. T-cell receptor contact and MHC binding residues of a major rye grass pollen allergen T-cell epitope.
    Burton MD; Blaher B; Suphioglu C; O'Hehir RE; Carbone FR; Rolland JM
    J Allergy Clin Immunol; 1999 Feb; 103(2 Pt 1):255-61. PubMed ID: 9949316
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Elimination of immunodominant epitopes from multispecific DNA-based vaccines allows induction of CD8 T cells that have a striking antiviral potential.
    Riedl P; Wieland A; Lamberth K; Buus S; Lemonnier F; Reifenberg K; Reimann J; Schirmbeck R
    J Immunol; 2009 Jul; 183(1):370-80. PubMed ID: 19542448
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HLArestrictor--a tool for patient-specific predictions of HLA restriction elements and optimal epitopes within peptides.
    Erup Larsen M; Kloverpris H; Stryhn A; Koofhethile CK; Sims S; Ndung'u T; Goulder P; Buus S; Nielsen M
    Immunogenetics; 2011 Jan; 63(1):43-55. PubMed ID: 21079948
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Structural basis for clonal diversity of the human T-cell response to a dominant influenza virus epitope.
    Yang X; Chen G; Weng NP; Mariuzza RA
    J Biol Chem; 2017 Nov; 292(45):18618-18627. PubMed ID: 28931605
    [TBL] [Abstract][Full Text] [Related]  

  • 33. From ZikV genome to vaccine: in silico approach for the epitope-based peptide vaccine against Zika virus envelope glycoprotein.
    Alam A; Ali S; Ahamad S; Malik MZ; Ishrat R
    Immunology; 2016 Dec; 149(4):386-399. PubMed ID: 27485738
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunoinformatic Identification of Potential Epitopes.
    Desai P; Tarwadi D; Pandya B; Yagnik B
    Methods Mol Biol; 2020; 2131():265-275. PubMed ID: 32162260
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mutations in a dominant Nef epitope of simian immunodeficiency virus diminish TCR:epitope peptide affinity but not epitope peptide:MHC class I binding.
    Cale EM; Bazick HS; Rianprakaisang TA; Alam SM; Letvin NL
    J Immunol; 2011 Sep; 187(6):3300-13. PubMed ID: 21841125
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Equivalent T cell epitope promiscuity in ecologically diverse human pathogens.
    Wiens KE; Swaminathan H; Copin R; Lun DS; Ernst JD
    PLoS One; 2013; 8(8):e73124. PubMed ID: 23951341
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In silico identification of potential epitopes present in human adenovirus proteins for vaccine design and of putative drugs for treatment against viral infection.
    Hossain R; Yasmin T; Hosen MI; Nabi AHMN
    J Immunol Methods; 2018 Apr; 455():55-70. PubMed ID: 29371093
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Length Distribution of Class I-Restricted T Cell Epitopes Is Determined by Both Peptide Supply and MHC Allele-Specific Binding Preference.
    Trolle T; McMurtrey CP; Sidney J; Bardet W; Osborn SC; Kaever T; Sette A; Hildebrand WH; Nielsen M; Peters B
    J Immunol; 2016 Feb; 196(4):1480-7. PubMed ID: 26783342
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Understanding the B and T cell epitopes of spike protein of severe acute respiratory syndrome coronavirus-2: A computational way to predict the immunogens.
    Vashi Y; Jagrit V; Kumar S
    Infect Genet Evol; 2020 Oct; 84():104382. PubMed ID: 32473352
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Discovery of promiscuous HLA-II-restricted T cell epitopes with TEPITOPE.
    Bian H; Hammer J
    Methods; 2004 Dec; 34(4):468-75. PubMed ID: 15542373
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.